Results 31 to 40 of about 1,610,894 (277)
Immune-checkpoint inhibitors have deeply changed the therapeutic landscape of advanced non-small cell lung cancer without actionable genomic alterations. Immune-checkpoint inhibitors have become standard front-line therapy, especially among patients with
Alex Friedlaender +2 more
doaj +1 more source
PD-1 blockade enhances chemotherapy toxicity in oesophageal adenocarcinoma
Chemotherapy upregulates immune checkpoint (IC) expression on the surface of tumour cells and IC-intrinsic signalling confers a survival advantage against chemotherapy in several cancer-types including oesophageal adenocarcinoma (OAC).
Maria Davern +10 more
doaj +1 more source
The development of multidrug resistance (MDR) against chemotherapeutic agents has become a major impediment in cancer therapy. Understanding the underlying mechanism behind MDR can guide future treatment for cancer with better therapeutic outcomes ...
Prathap Somu +7 more
doaj +1 more source
Vaccine-mediated cancer treatment is unlikely to induce long-term survival unless suppressive mechanisms are overcome. Given the success of antibody-mediated immune checkpoint blockade in relieving regulation of endogenous anti-tumor T cell responses in ...
Cameron S. Field +5 more
doaj +1 more source
Supplementary Table from A Pan-Cancer Immunogenomic Atlas for Immune Checkpoint Blockade ...
Jing Wang (6206297) +5 more
core +1 more source
Broadening activity of checkpoint blockade agents by intratumoral nucleoside cleavage
We investigated whether destroying malignant cells and the associated tumor microenvironment (TME) by focal gene therapy would broaden immune checkpoint inhibitor (ICI) effectiveness. We show that ICI antitumor activity against syngeneic (murine) triple-negative breast cancer (TNBC) was augmented when a therapeutic transgene ...
Regina Rab +11 more
openaire +2 more sources
Neoadjuvant immune-checkpoint blockade in resectable colon cancer
Neoadjuvant checkpoint blockade achieves deep or complete pathologic responses in patients with mismatch-repair-deficient and mismatch-repair-proficient early colon ...
Coukos, G., George Coukos, Coukos G
core +1 more source
Supplementary Data from A Pan-Cancer Immunogenomic Atlas for Immune Checkpoint Blockade ...
Jing Wang (6206297) +5 more
core +1 more source
The advent of immune checkpoint (ICP) blockade has introduced an unprecedented paradigm shift in the treatment of cancer. Though very promising, there is still a substantial proportion of patients who do not respond or develop resistance to ICP blockade.
Barbara Castella +6 more
doaj +1 more source
Diagnosis and Management of Hepatitis in Patients on Checkpoint Blockade
Many human tumors are recognized by the adaptive immune system, but these spontaneous antitumor responses are typically inadequate to mediate regression.
Kerry Reynolds +2 more
core +1 more source

